Table 2.
Correlation between clinic pathological characteristics and miR-381-3p expression levels in ccRCC patients.
| Characteristics | Number of patients | miR-381-3p | χ2 | p Value | |
|---|---|---|---|---|---|
| High expression (%) | Low expression (%) | ||||
| Sex | 118 | 119 | 0.362 | 0.548 | |
| Male | 161 | 78 (66.11) | 83 (69.75) | ||
| Female | 76 | 40 (33.89) | 36 (30.25) | ||
| Age | 0.844 | 0.358 | |||
| ≤65 | 158 | 82 (69.50) | 76 (63.87) | ||
| >65 | 79 | 36 (30.50) | 43 (36.13) | ||
| TNM stage | 7.813 | 0.005 | |||
| I | 121 | 71 (60.17) | 50 (42.02) | ||
| II+III+IV | 116 | 47 (39.83) | 69 (57.98) | ||
| Grade | 0.035 | 0.851 | |||
| Grade 1 + grade 2 | 101 | 51 (43.22) | 50 (42.02) | ||
| Grade 3 + grade 4 | 136 | 67 (56.78) | 69 (57.98) | ||
| Lymph node metastasis | 0.585 | 0.444 | |||
| No | 95 | 46 (38.99) | 49 (41.18) | ||
| Yes | 8 | 5 (4.24) | 3 (2.53) | ||